Gene · 1666
Papers3,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GIPC1 governed ferroptosis by regulating DECR1-modulating lipid homeostasis during dilated cardiomyopathy (DCM). | Cell Death Differ | 2026 | 41787053 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Exploring Deleterious Nonsynonymous SNPs in the ACADM Gene: Insights Into Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) via In Silico Analysis. | Genet Res (Camb) | 2026 | 41767627 | PubTator, text mining | PubMed |
| Proteomic signatures of intermittent pneumatic compression in patients with large artery atherosclerotic stroke. | iScience | 2026 | 41767269 | PubTator, text mining | PubMed |
| NCF2 facilitates M2 macrophage polarization in glioblastoma through activation of the notch1-osteopontin axis. | Front Immunol | 2026 | 41766892 | PubTator, text mining | PubMed |
| Hippocampal Bioenergetics and Metabolic Profiling Identifies Fatty Acid Oxidation as a Potential Therapeutic Target in Traumatic Brain Injury. | Mol Neurobiol | 2026 | 41764101 | PubTator, text mining | PubMed |
| Glutamine Supplementation and Exercise: A Narrative Review of Biochemical Mechanisms and Timing Strategies. | Medicina (Kaunas) | 2026 | 41752728 | PubTator, text mining | PubMed |
| Ferroptosis Suppressor Protein 1 (FSP1)-CoQ10-NADPH-Axis Is Responsible for Erastin Resistance in MCF-7 Breast Cancer Cells. | Antioxidants (Basel) | 2026 | 41750619 | PubTator, text mining | PubMed |
| Inducing Ferroptosis: Sensitization Strategy for Radiotherapy and Its Application. | Antioxidants (Basel) | 2026 | 41750617 | PubTator, text mining | PubMed |
| A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone. | FEBS J | 2026 | 41741972 | PubTator, text mining | PubMed |
| TRIM16: a context-dependent E3 ligase in autophagy, oxidative stress, and immune regulation - from cancer and systemic disease. | Front Oncol | 2026 | 41717414 | PubTator, text mining | PubMed |
| Placental iron utilisation in fetal growth restriction: alterations in mitochondrial haem synthesis and iron-sulphur cluster assembly pathways. | J Physiol | 2026 | 41697720 | PubTator, text mining | PubMed |
| Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis. | Biomedicines | 2026 | 41595737 | PubTator, text mining | PubMed |
| Lactylation Plays a Novel Role in the Tumor Microenvironment and its Prognostic Implications for Breast Cancer. | Recent Pat Anticancer Drug Discov | 2026 | 41582583 | PubTator, text mining | PubMed |
| Helicobacter pylori and Cancer: What's the Link? | Clin Exp Gastroenterol | 2026 | 41531650 | PubTator, text mining | PubMed |
| AKR1B1 bridges metabolic pathways and disease progression. | Cell Signal | 2026 | 41397670 | PubTator, text mining | PubMed |
FTO-Mediated m6A Demethylation of MZF1 Regulates DECR1 to Promote Fatty Acid Oxidation and Exacerbate Myocardial Ischemia/Reperfusion Injury : FTO-Mediated m6A Demethylation of MZF1 Enhances Fatty Acid Oxidation and Aggravates Myocardial I/R Injury. | Biochem Genet | 2026 | 41003915 | PubTator, text mining | PubMed |
| Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies. | Prostate Cancer Prostatic Dis | 2026 | 39733054 | PubTator, text mining | PubMed |
| Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth. | Front Pharmacol | 2025 | 41737012 | PubTator, text mining | PubMed |
| Anilin – Addendum: Reevaluierung des BAT-Wertes und Evaluierung einer Schwangerschaftsgruppe zum BAT-Wert: Beurteilungswerte in biologischem Material. | MAK Collect Occup Health Saf | 2025 | 41586736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1666/papers?page=2